Drug intelligence / Profile preview

(5R)-5-{[(2-Amino-3H-purin-6-yl)oxy]methyl}-2-pyrrolidinone

Development stage
Unknown
Modality
Small Molecules
01

Overview

(5R)-5-{[(2-Amino–3H-purin–6‑yl)oxy]methyl}‑2‑pyrrolidinone is a synthetic small molecule and an O^6-substituted guanine derivative. It contains a purine base structure similar to guanine, with a pyrrolidinone ring attached via an ether linkage at the 6-position of the purine. The compound is classified as experimental and has not been approved for any therapeutic use or clinical indication. Its mechanism of action is not well characterized, but it may be used in biochemical research as a nucleoside analog or for studying interactions with enzymes such as cyclin-dependent kinase 2 (CDK2), based on its structural similarity to known ligands. No clinical trials or approved indications are reported.

Other names
(5R)-5-{[(2-Amino-3H-purin-6-yl)oxy]methyl}-2-pyrrolidinone(5R)-5-{[(2-Amino-3H-purin-6-yloxy)methyl]}pyrrolidinone5-{[(2-AMINO–9H-PURIN–6-YL)OXY]METHYL}-2-PYRROLIDINONE(5R)-5-{[(2-amino–9H-purin–6-yloxy)]methyl}pyrrolidin–2-one

Beyond the preview

Go deeper on (5R)-5-{[(2-Amino-3H-purin-6-yl)oxy]methyl}-2-pyrrolidinone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (5R)-5-{[(2-Amino-3H-purin-6-yl)oxy]methyl}-2-pyrrolidinone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call